{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:54:02Z","timestamp":1761630842742,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["CP09.04"],"award-info":[{"award-number":["CP09.04"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.humimm.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T22:58:02Z","timestamp":1540508282000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Infection with a virus generates a polyclonal immune response with broad alloreactive potential"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-798X","authenticated-orcid":false,"given":"Heleen","family":"van den Heuvel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.W.","family":"van der Meer-Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula P.M.C.","family":"van Miert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline D.H.","family":"Anholts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans H.J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2018.10.014_b0005","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.014_b0010","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/01.TP.0000131158.81346.64","article-title":"Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules","volume":"77","author":"Gamadia","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.10.014_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012120","article-title":"Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules","volume":"5","author":"Morice","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2018.10.014_b0020","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1097\/01.ASN.0000085020.78117.70","article-title":"Memory T cells: a hurdle to immunologic tolerance","volume":"14","author":"Lakkis","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.10.014_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2018.10.014_b0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.qco.0000172698.52408.be","article-title":"Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens","volume":"18","author":"Singh","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.humimm.2018.10.014_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.10.014_b0040","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/ajt.12324","article-title":"Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients","volume":"13","author":"Arnold","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0045","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-6143.2012.04342.x","article-title":"Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion","volume":"13","author":"Lo","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0055","article-title":"Belatacept for kidney transplant recipients","volume":"11","author":"Masson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.humimm.2018.10.014_b0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0065","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1097\/TP.0000000000001755","article-title":"A randomized controlled clinical trial comparing belatacept with tacrolimus after de novo kidney transplantation","volume":"101","author":"de Graav","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.10.014_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-61779-842-9_19","article-title":"Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cells","volume":"882","author":"D'Orsogna","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.humimm.2018.10.014_b0075","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/ajt.14279","article-title":"Allo-HLA cross-reactivities of cytomegalovirus-, influenza-, and varicella zoster virus-specific memory T cells are shared by different healthy individuals","volume":"17","author":"van den Heuvel","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0080","doi-asserted-by":"crossref","first-page":"34324","DOI":"10.1074\/jbc.M606755200","article-title":"Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry","volume":"281","author":"Archbold","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2018.10.014_b0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/icb.2010.150","article-title":"The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection","volume":"89","author":"Gras","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.humimm.2018.10.014_b0090","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/TP.0b013e3181ff4ff3","article-title":"Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients","volume":"90","author":"Mifsud","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.10.014_b0095","article-title":"Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation","volume":"8","author":"Nguyen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2018.10.014_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOT.0000000000000264","article-title":"Deciphering the clinical relevance of allo-human leukocyte antigen cross-reactivity in mediating alloimmunity following transplantation","volume":"21","author":"Rowntree","year":"2016","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0105","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/ajt.13618","article-title":"Virus-specific CD8(+) T cells cross-reactive to donor-alloantigen are transiently present in the circulation of kidney transplant recipients infected with CMV and\/or EBV","volume":"16","author":"Heutinck","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.10.014_b0110","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.4049\/jimmunol.1201034","article-title":"Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules","volume":"189","author":"D'Orsogna","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2018.10.014_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humimm.2017.10.019","article-title":"The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression","volume":"79","author":"van den Heuvel","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.10.014_b0120","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.014_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antiviral Res."},{"issue":"480","key":"10.1016\/j.humimm.2018.10.014_b0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479","author":"Kahan","year":"2015","journal-title":"Virology"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918301836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918301836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T08:40:42Z","timestamp":1572252042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918301836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0198885918301836"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.10.014","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection with a virus generates a polyclonal immune response with broad alloreactive potential","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}